Delving into the Latest Updates on Chengdu Olymvax Biopharmaceuticals, Inc. with Synapse

Overview

Tags

Infectious Diseases

Other Diseases

Respiratory Diseases

Prophylactic vaccine

Conjugated vaccine

Monoclonal antibody

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	15
Nervous System Diseases	1

Top 5 Drug Type	Count

Prophylactic vaccine	8
Conjugated vaccine	5
Monoclonal antibody	2
Toxoid vaccine	1
Fusion protein	1

Top 5 Target	Count

Varicella-zoster virus gH/gL	1
MPEG1(macrophage expressed 1)	1
IgG(Immunoglobulin G)	1
alpha-toxin(Alpha-hemolysin)	1

Objective To develop a method for rejuvenating Sreptococcus pneumoniae serotype 19F(PN19F) and optimize the purification process of capsular polysaccharide.Methods Liquid amplification medium and solid selective medium for PN19F were prepared for screening single colonies with thick capsule.The fermentation of PN19F before and after rejuvenating as well as the yield and quality of purified polysaccharides were compared.The fermentation liquid was lysed and subjected to acid precipitation for 8,24 and 48 h,then purified by 100 KD ultrafiltration to obtain polysaccharides by ethanol method and freeze-drying method resp.The polysaccharide harvest,component test result,antigen activity and ∼1H-NMR were compared.Results The A600 value and culture time of fermentation harvest of PN19F before and after rejuvenating showed no significant change.After purification,the yields of purified polysa-ccharides were 0. 2 and 0. 6 g/L resp.,which increased by 195% as compared with those before rejuvenating.The polysaccharides after purification by acid precipitation for 8 and 24 h were qualified,of which the yield after purification for 24 h was about 38% higher than that for 8 h.However,after acid precipitation for 48 h,the yield showed no significant change,while the polysaccharide quality was unqualified.All the indexes of purified polysaccharides prepared by ethanol method and lyophilization method were qualified,which showed no significant difference.Conclusion PN19F strain rejuvenated by two media increased the yield of polysaccharide singificnatly.The acid precipitation time was less than 24 h.Both ethanol method and lyophilization method may be used for the preparation of purified polysaccharide.

100 Deals associated with Chengdu Olymvax Biopharmaceuticals, Inc.

Login to view more data

100 Translational Medicine associated with Chengdu Olymvax Biopharmaceuticals, Inc.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

3

8

Preclinical

IND Approval

3

1

Phase 2 Clinical

Phase 3 Clinical

1

3

Approved

Other

1

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Hib conjugate vaccine(Chengdu Olymvax Biopharmaceuticals, Inc.)	Haemophilus Infections More	Approved
Tetanus Vaccine,Adsorbed(Chengdu Olymvax Biopharmaceuticals, Inc.)	Tetanus More	Approved
A/C meningococcal conjugate vaccine(Olymvax Biopharmaceuticals)	Meningitis More	Approved
Recombinant Staphylococcus Aureus(Escherichia Coli)(Chongqing Yuanlun Biotechnology)	Staphylococcus Aureus Infections More	Phase 3
Recombinant Staphylococcus Aureus(Chengdu Olymvax Biopharmaceuticals, Inc.)	Staphylococcus Aureus Infections More	Phase 2